The Justice Department aims to block two mammoth health insurance mergers, but insurers aren't taking this rejection lying down.
Want bigger dividend payouts? These three stocks may soon oblige.
Despite its looming lawsuit with Anthem, the pharmacy benefits manager boosted its expectations for customer renewals.
Some big names in the insurance industry are waving the white flag on Obamacare.
Anthem's revenue and profit came in ahead of projections, but investors' attention is squarely focused on a new lawsuit with the DOJ.
Looking for bargains in the sector best positioned to ride aging demographic trends? These five are screaming buys.
Here's what investors will be looking for in the pharmacy benefits manager's upcoming earnings release and conference call.
The American population is getting older, which is a big reason our contributors are bullish on these three stocks.
The main thing: When the profits are this good, the big picture doesn't matter.
CEO George Paz says Anthem's demands for $3 billion in annual savings are "ludicrous."